巨衍生的LCN2促进甲基胺诱导的肺高血压
Jie Zhou1, Zhenzhen Xu1, Dao-Bo Peng2
1Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, P.R. China (J.Z., Z.X., X.L., S.C., K.D., Y.J., C.G., X.P., W.-B.X.).
利波卡林2 (LCN2) 在甲基胺诱导的肺高血压 (METH-PH) 中起着关键作用. LCN2缺乏通过减少炎症和血管重塑来保护METH-PH,这表明LCN2是治疗点.
科学领域:
- 肺血管疾病是肺血管疾病.
- 炎症和免疫学 炎症和免疫学
- 细胞和分子机制的机制
背景情况:
- 甲基胺 (METH) 的使用与肺高血压 (PH) 有关.
- 巨细胞活化对PH发育至关重要,但METH诱导的PH机制尚未完全理解.
研究的目的:
- 调查Lipocalin 2 (LCN2) 在METH诱导PH (METH-PH) 中的作用和机制.
主要方法:
- 使用野生类型和LCN2淘汰赛 (LCN2-/-) 的小鼠建立了一个METH-PH小鼠模型.
- 利用巨细胞和肺动脉光滑肌细胞的共同培养系统来探索机制.
主要成果:
- 在METH-PH小鼠的肺巨中,LCN2表达升高.
- LCN2-/-小鼠显示对METH-PH的保护,血管重塑和右心室压力降低.
- 通过NLRP3炎症酶激活,LCN2通过NLRP3炎症酶激活来调节IL-1β的产生,并在光滑肌细胞中调节SLC7A11/GPX4,减少活性氧物种和铁亡.
结论:
- LCN2是METH-PH中周血管炎症和血管重塑的关键调节者.
- 在METH-PH中发现了一种涉及LCN2,巨细胞,炎症和细胞间信号传递的新机制.
- LCN2代表了METH诱导PH的潜在治疗标.
更多相关视频
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
相关概念视频
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
